Contents of this document
- Factors behind the increase403 Millions of yen
- Factors reducing profit-256 Millions of yen
- Factors reducing profit-50 Millions of yen
- Post-M&A PMI initiatives
- Online platform rollout for MedMarge
- Opening of OIMACHI TRACKS and BtoC initiatives
- E-commerce site UI/UX improvements
- WMS implementation and development of logistics facilities
- BtoB revenue2,335 Millions of yenYear on year against the same period last year+6.1%
- BtoB PB sales ratio47 %Year on year against the same period last year+2.6%
- BtoC private-brand revenue210 Millions of yenYear on year against the same period last year+18.9%
- Number of active customers18,372 UU
- Average order value¥3.1 thousand
| Item | Details |
|---|---|
| Document type | Financial Results Presentation |
| Fiscal Period Covered | Second quarter (interim period) of the fiscal year ending September 2026 |
| Net Sales | 8,419 Millions of yen (YoY +22.3%) |
| Operating profit | 647 Millions of yen (YoY +17.7%) |
| Ordinary income | 571 Millions of yen (YoY +2.2%) |
| Net income | 368 Millions of yen (YoY +4.7%) |
| Gross Profit Margin | 29.9 % |
| Operating profit margin | 7.7 % |
| Selling, general and administrative expenses | 1,866 Millions of yen |
| Results for the three months of the current quarter | Standalone second-quarter KPIs included BtoB revenue of ¥1,105 million, BtoC revenue of ¥725 million, and private-brand revenue of ¥210 million. Standalone three-month consolidated income statement figures are Not disclosed. |
| Full-year earnings forecast | Net Sales 15,109 Millions of yen / Operating profit 812 Millions of yen / Ordinary income 830 Millions of yen / Net income 477 Millions of yen |
| Progress against full-year forecast | Net Sales 55.7 / Operating profit 79.7 / Ordinary income 78.1 / Net income 77.2 |
| Segment results | Trends in revenue and KPIs for the BtoB and BtoC businesses are provided, but a clear breakdown of segment profit is Not disclosed. |
| Breakdown of Factors Affecting the Change | Factors Factors behind the increase / Amount 403 Millions of yen, Factors Factors reducing profit / Amount -256 Millions of yen, Factors Factors reducing profit / Amount -50 Millions of yen |
| Key KPIs | Indicator name BtoB revenue / Value 2,335 Millions of yen / Year on year against the same period last year 6.1 Millions of yen, Indicator name BtoB PB sales ratio / Value 47 % / Year on year against the same period last year 2.6 %, Indicator name BtoC private-brand revenue / Value 210 Millions of yen / Year on year against the same period last year 18.9 Millions of yen, Indicator name Number of active customers / Value 18,372 UU / Year on year against the same period last year Not disclosed, Indicator name Average order value / Value ¥3.1 thousand / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Number of active customers 18,372 UU / Average order value ¥3.1 thousand |
| Medium-term management plan targets | The company outlined its direction toward 2030, including the expansion of its BtoB and BtoC businesses, but numerical targets are Not disclosed. |
| New initiatives | Post-M&A PMI initiatives, Online platform rollout for MedMarge, Opening of OIMACHI TRACKS and BtoC initiatives, E-commerce site UI/UX improvements, WMS implementation and development of logistics facilities |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited contributions from M&A, expansion of its BtoB and BtoC businesses, and progress in e-commerce and other new initiatives. For operating profit, the company cited factors contributing to a ¥403 million increase, as well as factors contributing to decreases of ¥256 million and ¥50 million.